Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19-a randomised double-blinded placebo-controlled trial.

Pradeesh SivapalanCharlotte Suppli UlrikTherese Sophie LapperreRasmus Dahlin BojesenJosefin EklöfAndrea BrowatzkiJon Torgny WilckeVibeke GottliebKjell Erik Julius HåkanssonCasper TidemandsenOliver TupperHowraman MeteranChristina BergsøeEva BrøndumUffe BodtgerDaniel Bech RasmussenSidse Graff JensenLars PedersenAlexander JordanHelene PrieméChristian SøborgIda E SteffensenDorthe HøgsbergTobias Wirenfeldt KlausenMartin Steen FrydlandPeter LangeAsger SverrildMuhzda GhanizadaFilip Krag KnopTor Biering-SørensenJens D LundgrenJens-Ulrik Stæhr Jensennull null

Published in: The European respiratory journal (2021)

The combination of azithromycin and hydroxychloroquine did not improve survival or length of hospitalisation in patients with COVID-19.

Keyphrases

double blind
coronavirus disease
sars cov
study protocol
clinical trial
placebo controlled
open label
free survival
randomized controlled trial
respiratory syndrome coronavirus
community acquired pneumonia